We then analyzed the correlation between ATAD2 expression and clinicopathological features, and ATAD2 expression was found to be significantly associated with lymph node metastasis (P = 0.002) and advanced stage (P = 0.028) (Table 1). This evidence concerns the gene ATAD2 and metastatic malignant neoplasm in the lymph nodes.